rs1378942

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NM_004383.3(CSK):c.-66+2306C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.434 (AC=66,036) in the gnomAD database across 152,054 control chromosomes, including 18,755 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.652. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.43 ( 18755 hom., cov: 32)

Consequence

CSK
NM_004383.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0300

Publications

213 publications found
Variant links:
Genes affected
CSK (HGNC:2444): (C-terminal Src kinase) The protein encoded by this gene is involved in multiple pathways, including the regulation of Src family kinases. It plays an important role in T-cell activation through its association with the protein encoded by the protein tyrosine phosphatase, non-receptor type 22 (PTPN22) gene. This protein also phosphorylates C-terminal tyrosine residues on multiple substrates, including the protein encoded by the SRC proto-oncogene, non-receptor tyrosine kinase gene. Phosphorylation suppresses the kinase activity of the Src family tyrosine kinases. An intronic polymorphism (rs34933034) in this gene has been found to affect B-cell activation and is associated with systemic lupus erythematosus (SLE). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_004383.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Benign. The variant received -12 points.

BP4
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BA1
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.6516 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_004383.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CSK
NM_004383.3
MANE Select
c.-66+2306C>A
intron
N/ANP_004374.1B2R6Q4
CSK
NM_001127190.2
c.-66+2306C>A
intron
N/ANP_001120662.1P41240
CSK
NM_001387089.1
c.-87+2306C>A
intron
N/ANP_001374018.1B2R6Q4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CSK
ENST00000220003.14
TSL:1 MANE Select
c.-66+2306C>A
intron
N/AENSP00000220003.9P41240
CSK
ENST00000563894.1
TSL:1
n.217+2306C>A
intron
N/A
CSK
ENST00000439220.6
TSL:2
c.-66+2306C>A
intron
N/AENSP00000414764.2P41240

Frequencies

GnomAD3 genomes
AF:
0.435
AC:
66060
AN:
151936
Hom.:
18762
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.116
Gnomad AMI
AF:
0.457
Gnomad AMR
AF:
0.359
Gnomad ASJ
AF:
0.562
Gnomad EAS
AF:
0.175
Gnomad SAS
AF:
0.199
Gnomad FIN
AF:
0.550
Gnomad MID
AF:
0.535
Gnomad NFE
AF:
0.657
Gnomad OTH
AF:
0.453
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.434
AC:
66036
AN:
152054
Hom.:
18755
Cov.:
32
AF XY:
0.421
AC XY:
31275
AN XY:
74310
show subpopulations
African (AFR)
AF:
0.116
AC:
4800
AN:
41480
American (AMR)
AF:
0.358
AC:
5472
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.562
AC:
1949
AN:
3470
East Asian (EAS)
AF:
0.175
AC:
904
AN:
5174
South Asian (SAS)
AF:
0.197
AC:
950
AN:
4816
European-Finnish (FIN)
AF:
0.550
AC:
5808
AN:
10556
Middle Eastern (MID)
AF:
0.544
AC:
160
AN:
294
European-Non Finnish (NFE)
AF:
0.657
AC:
44632
AN:
67964
Other (OTH)
AF:
0.449
AC:
945
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1458
2917
4375
5834
7292
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
572
1144
1716
2288
2860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.571
Hom.:
86040
Bravo
AF:
0.414
Asia WGS
AF:
0.166
AC:
581
AN:
3478

Local populations

ToMMo 61KJPN (+60KJPN MNV)
AF:
0.205
AC:
25089
AN:
122680
Turkish Variome
AF:
0.505
AC:
780
AN:
1544
Hom.:
202
WBBC (Westlake BioBank for Chinese) pilot
AF:
0.157
AC:
1407
AN:
8960
Hom.:
117
ABraOM SABE-WGS-1171
AF:
0.450
AC:
1054
AN:
2342
Hom.:
267

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
2.3
DANN
Benign
0.46
PhyloP100
-0.030
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.